Difficulty: Medium
Average Score: 64%
Practice
Which of the following statements about vancomycin is accurate?
Correct answer
C
Rationale
In the context of a Drugs and immune system exam, the accurate statement about vancomycin is option C) It is not susceptible to penicillinase. This is because vancomycin is a glycopeptide antibiotic that works by inhibiting cell wall synthesis in bacteria, making it effective against a wide range of gram-positive bacteria including those resistant to beta-lactam antibiotics like penicillin. Vancomycin achieves its bactericidal effect by binding to the D-Ala-D-Ala terminus of cell wall precursors, thereby preventing cross-linking of peptidoglycan chains.
Option A) It is bacteriostatic is incorrect because vancomycin is actually bactericidal, meaning it kills bacteria rather than just inhibiting their growth.
Option B) It binds to PBPs is incorrect as vancomycin acts by binding to the D-Ala-D-Ala terminus of cell wall precursors, not to penicillin-binding proteins (PBPs) which are the target of beta-lactam antibiotics.
Option D) It has the advantage of oral bioavailability is incorrect because vancomycin has very poor oral bioavailability and is typically administered intravenously to achieve therapeutic levels.
Understanding the mechanism of action and characteristics of vancomycin is crucial in clinical practice to ensure appropriate use of this antibiotic and to prevent the development of antibiotic resistance. This knowledge is essential for healthcare professionals involved in prescribing, administering, and monitoring patients receiving vancomycin therapy.
Option A) It is bacteriostatic is incorrect because vancomycin is actually bactericidal, meaning it kills bacteria rather than just inhibiting their growth.
Option B) It binds to PBPs is incorrect as vancomycin acts by binding to the D-Ala-D-Ala terminus of cell wall precursors, not to penicillin-binding proteins (PBPs) which are the target of beta-lactam antibiotics.
Option D) It has the advantage of oral bioavailability is incorrect because vancomycin has very poor oral bioavailability and is typically administered intravenously to achieve therapeutic levels.
Understanding the mechanism of action and characteristics of vancomycin is crucial in clinical practice to ensure appropriate use of this antibiotic and to prevent the development of antibiotic resistance. This knowledge is essential for healthcare professionals involved in prescribing, administering, and monitoring patients receiving vancomycin therapy.